Macular Corneal Dystrophy Clinical Trial
Official title:
Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex-Smile Surgery
Verified date | February 2024 |
Source | Eye Hospital Pristina Kosovo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is to examine the effect of fresh corneal lenticule implantation as allogenic graft taken from myopic patients to implanted in patients with macular corneal dystrophy using Visumax Femtosecond Laser Smile module surgery.
Status | Enrolling by invitation |
Enrollment | 15 |
Est. completion date | June 1, 2025 |
Est. primary completion date | June 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 55 Years |
Eligibility | Inclusion Criteria: - indications for penetrating keratoplasty - low transparec of corneae - low visual acuity Exclusion Criteria: - active anterior segment pathology - previous corneal or anterior segment surgery - any infection |
Country | Name | City | State |
---|---|---|---|
Kosovo | Eye Hospital Pristina | Pristina |
Lead Sponsor | Collaborator |
---|---|
Eye Hospital Pristina Kosovo |
Kosovo,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Increase of corneal transparency | Implanting fresh corneal lenticule we add more live stem cells and keratocytes to stabilize biomechanical stability of cornea. Also making flap and putting autologous serum after one month of implanting fresh corneal lenticule we removed more dead keratocytes from macula dystrophia and added more live keratocytes which contributed to the regeneration of the cornea. | 12 months | |
Secondary | Increase of visual acuity | After implanting fresh corneal lenticule according to clarity of cornea visual acuity increased for 2-3 m and also softening symptoms of corneal dystrophy ex. dry eyes, sensitivity to light, pain in the eye, corneal erosion etc. | 12 months |